NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Longeveron Inc (NASDAQ: LGVN)
LGVN Technical Analysis
3
As on 25th Apr 2025 LGVN STOCK Price closed @ 1.75 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.74 & Buy for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LGVNSTOCK Price
Open | 1.67 | Change | Price | % |
High | 1.75 | 1 Day | 0.12 | 7.36 |
Low | 1.62 | 1 Week | 0.29 | 19.86 |
Close | 1.75 | 1 Month | 0.11 | 6.71 |
Volume | 153997 | 1 Year | -0.19 | -9.79 |
52 Week High 4.55 | 52 Week Low 0.34 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
GNLN | 0.01 | -50.00% |
AGMH | 0.05 | 25.00% |
OMEX | 1.51 | 77.65% |
NVDA | 111.01 | 4.30% |
WW | 0.40 | 166.67% |
TSLA | 284.95 | 9.80% |
INTC | 20.05 | -6.70% |
OPEN | 0.76 | -2.56% |
LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
LGVN Daily Charts |
LGVN Intraday Charts |
Whats New @ Bazaartrend |
LGVN Free Analysis |
|
LGVN Important Levels Intraday
RESISTANCE | 2.00 |
RESISTANCE | 1.92 |
RESISTANCE | 1.87 |
RESISTANCE | 1.82 |
SUPPORT | 1.68 |
SUPPORT | 1.63 |
SUPPORT | 1.58 |
SUPPORT | 1.50 |
LGVN Forecast April 2025
4th UP Forecast | 5.2 |
3rd UP Forecast | 4.09 |
2nd UP Forecast | 3.41 |
1st UP Forecast | 2.73 |
1st DOWN Forecast | 0.77 |
2nd DOWN Forecast | 0.09 |
3rd DOWN Forecast | -0.59 |
4th DOWN Forecast | -1.7 |
LGVN Weekly Forecast
4th UP Forecast | 2.52 |
3rd UP Forecast | 2.27 |
2nd UP Forecast | 2.12 |
1st UP Forecast | 1.97 |
1st DOWN Forecast | 1.53 |
2nd DOWN Forecast | 1.38 |
3rd DOWN Forecast | 1.23 |
4th DOWN Forecast | 0.98 |
LGVN Forecast2025
4th UP Forecast | 13.45 |
3rd UP Forecast | 9.7 |
2nd UP Forecast | 7.38 |
1st UP Forecast | 5.06 |
1st DOWN Forecast | -1.56 |
2nd DOWN Forecast | -3.88 |
3rd DOWN Forecast | -6.2 |
4th DOWN Forecast | -9.95 |
Longeveron Inc ( NASDAQ USA Symbol : LGVN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LGVN Other Details
Segment | EQ | |
Market Capital | 66709956.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
LGVN Address
![]() |
LGVN Latest News
LGVN Business Profile
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida. Address: 1951 NW 7th Avenue, Miami, FL, United States, 33136
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service